The mode of anti-arthritic peptide delivery impacts on the severity and outcome of adjuvant induced arthritis

APLAR Journal of Rheumatology

Volumn 10, Issue 3, 2007, Pages 198-203

  Kurosaka, Nozomu ^a   Ali, Marina ^a   Byth, Karen ^b   Manolios, Nicholas ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Animal disease models; Immunosuppression; Peptides; T lymphocytes; Therapeutics

Indexed keywords

ANTIRHEUMATIC AGENT; CORE PEPTIDE; CYCLOSPORIN A; LIPID; NONAPEPTIDE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 34547490122     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2007.00289.x     Document Type: Article

References (9)

1. Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22 (Suppl. 1), 1-12.
2. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C (2004) The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: A comparative study. (Extended Report). Ann Rheumatic Dis 63, 395-401.
3. Doan T, Massarotti E (2005) Rheumatoid arthritis: An overview of new and emerging therapies. J Clin Pharmacol 45, 751-62.
4. Manolios N, Collier S, Taylor J, Pollard J, Harrison LC, Bender V (1997) T-cell antigen receptor transmembrane peptides modulate T-cell function and T-cell mediated disease. Nat Med 3, 84-8.
5. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW (2002) The Organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111, 967-79.
6. Gollner G, Muller G, Alt R, Knop J, Enk AH (2000) Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell mediated skin diseases. Gene Ther 7, 1000-4.
7. Mahnke K, Yingjie Q, Knop J, Enk AH (2003) Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen -specific immunosuppression in vivo. Nat Biotechnol 21, 903-8.
8. Ali M, Amon M, Bender V, Manolios N (2005) Hydrophobic transmembrane-peptide lipid conjugations enhance membrane binding and functional activity in T-cells. Bioconjugate Chem 16, 1556-63.
9. Shimizu T, Arai S, Imai H, et al. (2004) Glycoglycerolipid from the membranes of Acholeplasma laidlawii binds to human immunodeficiency virus-1 (HIV-1) and accelerates its entry into cells. Curr Microbiol 48, 182-8.